Wolverine Asset Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Wolverine Asset Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-800	Closed	-$5K	–	1434
2016 Q2	$5K	Buy	+800	New	+$6K	﹤0.01%	1164
2016 Q1	–	Sell	-653	Closed	-$6K	–	1836
2015 Q4	$6K	Buy	+653	New	+$4.29K	﹤0.01%	1478
2015 Q1	–	Sell	-313	Closed	-$2K	–	2396
2014 Q4	$2K	Hold	313	–	–	﹤0.01%	2007
2014 Q3	$2K	Hold	313	–	–	﹤0.01%	2317
2014 Q2	$5K	Sell	313 -1	-0.3%	-$7	﹤0.01%	2031
2014 Q1	$12K	Buy	+314	New	+$2.45K	﹤0.01%	1796

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Wolverine Asset Management's ARIA Position: Q2 2014 in Review

Wolverine Asset Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2014, closing a stake of 49,217 shares — an estimated $338K sold.

Wolverine Asset Management first reported a position in ARIA in Q2 2013 and held it in 4 quarters. The position peaked at $396K in Q1 2014. 169 funds tracked by Wall St. Rank hold ARIA as of Q2 2014.

Wolverine Asset Management reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
Wolverine Asset Management sold 49,217 Ariad Pharmaceuticals Inc shares in Q2 2014, an estimated $338K.
Wolverine Asset Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
Wolverine Asset Management's Ariad Pharmaceuticals Inc position peaked at $396K in Q1 2014.
169 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2014.

Based on Wolverine Asset Management's 13F filing for Q2 2014, filed 13 Aug 2014.